Xiangxue Pharmaceutical Co (SZSE:300147) Other Operating Expense : ¥312 Mil (TTM As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co Other Operating Expense?

Xiangxue Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2025 was ¥-2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was ¥312 Mil.

Xiangxue Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2024 (¥-144 Mil) to Dec. 2024 (¥354 Mil) but then declined from Dec. 2024 (¥354 Mil) to Mar. 2025 (¥-2 Mil).

Xiangxue Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2022 (¥285 Mil) to Dec. 2023 (¥275 Mil) but then increased from Dec. 2023 (¥275 Mil) to Dec. 2024 (¥313 Mil).

Xiangxue Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co Other Operating Expense Chart

Xiangxue Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

212.03

232.01

285.44

275.05

313.19

Xiangxue Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial															-1.72	104.78	-144.37	354.50	-2.48

Xiangxue Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥312 Mil.

Xiangxue Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangxue Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663

Website

http://www.xphcn.com

Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.

Executives

Huang Wei Hua	Supervisors
Tan Wen Hui	Director
Kang Zhi Ying	Executives
Ceng Lun	Executives
Liu Yan	Executives
Lu Feng	Executives
Xu Li	Secretary, Director
Mo Zi Yu	Supervisors
Mai Zhen Jiang	Supervisors
Wang Yong Hui	Directors, executives
He Tao	Executives
Fang Wei Min	Supervisors
Huang Bin	Directors, Directors, and Executives
Wu Jun	Executives
Chen Wen Jin	Executives

Xiangxue Pharmaceutical Co Headlines

No Headlines